How to calculate left ventricular mass in routine practice? An echocardiographic versus cardiac magnetic resonance study  by Perdrix, Ludivine et al.
Archives of Cardiovascular Disease (2011) 104, 343—351
CLINICAL RESEARCH
How to calculate left ventricular mass in routine
practice? An echocardiographic versus cardiac
magnetic resonance study
Comment calculer la masse ventriculaire gauche en routine ? Étude
comparative échocardiographie-imagerie par résonance magnétique
Ludivine Perdrixa,∗, Nicolas Mansencalb,
Benjamin Cocheteuxc, Gilles Chatellierd,
Alvine Bisserye, Benoit Diebolda, Elie Mousseauxc,
Eric Abergela
a Laboratoire d’échocardiographie, service de cardiologie, hôpital européen
Georges-Pompidou (HEGP), Assistance publique—Hôpitaux de Paris (AP—HP), 20, rue Leblanc,
75015 Paris, France
b Service de cardiologie, université de Versailles-Saint-Quentin, hôpital Ambroise-Paré,
AP—HP, 92100 Boulogne, France
c Inserm, service de radiologie, AP—HP, HEGP, imagerie cardiovasculaire, 75015 Paris, France
d CIE 4 Inserm, AP—HP, HEGP, 75015 Paris, France
e Inserm, centre d’investigation clinique, AP—HP, HEGP, 9201 Paris, France
Received 14 December 2010; received in revised form 6 April 2011; accepted 11 April 2011
KEYWORDS
Left ventricular mass;
Echocardiography;
Cardiac magnetic
resonance;
Summary
Background.— An accurate assessment of left ventricular (LV) mass is important for the detec-
tion of LV hypertrophy.
Aims.— To assess the accuracy of four echocardiographic imaging modalities for assessing LV
mass compared with cardiac magnetic resonance (CMR).Harmonic imaging;
Fundamental imaging
Methods.— We prospectively studied 40 consecutive patients, who underwent an echocardio-
graphic examination using four imaging modalities (M-mode fundamental imaging [FI], M-mode
harmonic imaging [HI], two-dimensional [2D] FI and 2D HI) and CMR (our gold standard for LV
mass measurement). All echocardiographic measurements were performed by two independent
observers.
Abbreviations: 2D, two-dimensional; ASE, American Society of Echocardiography; CMR, cardiac magnetic resonance; FI, fundamental
imaging; HI, harmonic imaging; ICC, intraclass correlation coefﬁcient; IVS, interventricular septum; LV, left ventricular; LVD, left ventricular
diameter; O1, observer 1; O2, observer 2; PW, posterior wall; SD, standard deviation.
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Results.— All echocardiographic modes signiﬁcantly overestimated LV mass compared with CMR
(P≤ 0.04), except 2D FI (P = 0.25). This overestimation was signiﬁcantly higher with HI (up to
15.5%) compared with FI (up to 5.7%; P≤ 0.04). Signiﬁcant correlations were observed between
the different echocardiographic methods and the two observers. The interobserver agreement
over LV mass measurement was lower with FI (intraclass coefﬁcient [ICC] range, 0.66—0.73)
than with HI (ICC range, 0.72—0.82), and the best agreement was obtained with 2D HI (ICC,
0.82). Good agreement between CMR and all echocardiographic methods was observed among
the smallest LV diameters (ICC range, 0.62—0.85), but not among the largest LV diameters (ICC
range, 0—0.22).
Conclusions.— HI overestimates LV mass compared with FI and CMR; this leads to overesti-
mation of prevalence of LV hypertrophy in a population of hypertensive patients. HI improves
interobserver reproducibility of LV mass measurement compared with FI, leading to a signiﬁcant
decrease in the number of patients required for clinical trials evaluating LV mass regression.
Accuracy of LV mass measurement by echocardiography is affected by LV geometry.
© 2011 Published by Elsevier Masson SAS.
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Résumé
Contexte.— La mesure de masse ventriculaire gauche doit être la plus précise possible pour la
détection de l’hypertrophie ventriculaire gauche.
Objectif.— L’objectif de cette étude est de comparer les quatre différentes modalités de
mesure de masse VG en échocardiographie entre elles et à l’IRM.
Méthodes.— Quarante patients ont été inclus prospectivement et ont bénéﬁcié d’une échocar-
diographie comprenant les différentes modalités de mesure (imagerie fondamentale TM,
imagerie harmonique TM, imagerie fondamentale 2D, imagerie harmonique 2D), et d’une IRM,
considérée comme la méthode de référence de mesure de masse VG. Toutes les mesures
échocardiographiques ont été faites par deux observateurs indépendants.
Résultats.— Toutes les méthodes de mesure échocardiographiques ont surestimé la mesure de
masse VG par rapport à l’IRM (p≤ 0,04), exceptée la méthode FI 2D (p = 0,25). Cette sures-
timation était supérieure en imagerie harmonique (jusqu’à 15,5 %), comparée à l’imagerie
fondamentale (jusqu’à 5,7 %; p≤ 0,04). Des corrélations signiﬁcatives ont été constatées entre
les différentes modalités échocardiographiques et entre les deux observateurs. La reproductibil-
ité inter-observateur était plus faible en imagerie fondamentale (coefﬁcient intraclasse [CCI]
0,66 à 0,73) qu’en imagerie harmonique (CCI 0,72 à 0,82), et la meilleure reproductibilité a
été obtenue en imagerie harmonique 2D (CCI = 0,82). Une bonne reproductibilité entre l’IRM et
toutes les modalités échocardiographiques a été observée parmi les petits VG (CCI 0,62 à 0,85),
contrairement aux grands VG (CCI 0 à 0,22).
Conclusions.— L’imagerie harmonique surestime la mesure de masse VG en comparaison
à l’imagerie fondamentale et à l’IRM, ce qui peut entraîner une surestimation du diag-
nostic d’hypertrophie ventriculaire gauche dans les populations d’hypertendus. L’imagerie
harmonique améliore la reproductibilité de mesure inter-observateur comparée à l’imagerie
fondamentale, ce qui pourrait permettre des échantillons de patients signiﬁcativement moins
grands pour les études cliniques de régression de masse VG. La précision de mesure de masse
VG est inﬂuencée par la géométrie VG.
© 2011 Publie´ par Elsevier Masso
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V hypertrophy is an independent risk factor for cardio-
ascular mortality and morbidity [1,2]; its regression in
ypertensive patients is associated with a reduced risk of
vents [3,4]. Therefore, measurement of LV mass is of
mportance for cardiovascular risk stratiﬁcation. CMR is
he reference method for measuring LV mass. However,
MR is not available in most centres and its accessi-
ility is restricted. Therefore, in routine practice, LV
ass is mainly estimated by echocardiography, which is
onsidered to be less accurate and reproducible than
MR.
•n SAS.
The only anatomically validated echocardiographic
ethod for LV mass measurement is M-mode FI [5]. How-
ver, LV mass is routinely measured by other less validated
chocardiographic methods: M-mode HI, which is currently
sed because of improved quality of imaging [6]; or 2D
arasternal long-axis views with FI or HI using M-mode equa-
ions [7,8]. In clinical trials evaluating LV mass modiﬁcation
ith drugs, all these approaches are indifferently used and
re generally not speciﬁed [9—14]. The aim of this prospec-
ive study using echocardiography and CMR was:
to assess the potential impact of different echocar-
diographic imaging methods on the accuracy and
reproducibility of LV mass measurement;
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Figure 1. Different echocardiographic methods for left ventric-
ular mass measurement. For each method (American Society of
Echocardiography [ASE], Penn, two-dimensional [2D]), harmonic
imaging and fundamental imaging were used. Ao: aorta; IVS: inter-
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• to analyse the potential inﬂuence of LV geometry in the
assessment of LV mass by echocardiography (Penn and ASE
methods).
Methods
Population
We prospectively included 40 consecutive patients with
hypertension who were referred for clinical consultation in
the hypertension clinic. Entry criteria included age greater
or equal to 18 years and sufﬁcient quality of echocardiog-
raphy for LV measurement. Patients were excluded in case
of contraindication to CMR. All included patients under-
went an echocardiographic examination and a CMR study
on the same day. CMR was considered as our gold stan-
dard for the measurement of LV mass. The study was
approved by the ethics committee of our university medi-
cal institution, and all participating patients gave informed
consent.
Cardiac magnetic resonance protocol
CMR examinations were performed using a 1.5-T imager
(Signa LX; GE Medical Systems, Milwaukee, WI, USA) with
a phased-array torso coil. Breath-hold electrocardiogram-
gated segmented cine fast imaging employing steady-state
excitation (FIESTA; GE Medical Systems) was performed in
long-axis views (four- and two-chamber views) and ﬁnally
in short-axis views. In all patients, 10 to 16 short-axis
cine loops were obtained from base to apex with a slice
thickness of 8mm with a 2-mm gap. CMR cine loops were
analysed ofﬂine with commercial software (Mass Analysis;
Medis, Leiden, The Netherlands). In each short-axis slice,
endocardial and epicardial contours were manually traced
at end-diastole, while papillary muscles were included in
the LV cavity. LV volumes were derived by summation of
discs and LV mass was calculated by subtracting endocar-
dial from epicardial volume at end-diastole and multiplying
by 1.05 g/cm3. All CMR measurements were interpreted by
an experienced investigator (E.M.) who was blinded to the
echocardiographic results. For each patient, the traced con-
tours were used to calculate LV mass, which served as the
reference.
Echocardiography
The same senior physician (E.A.) performed all echocar-
diographic examinations using an HDI 5000 (Advanced
Technology Laboratories, Bothell, WA, USA) echocardio-
graphic system equipped with a multifrequency transducer.
For each patient, measurement of LV mass was performed
in the parasternal long-axis view using two different modali-
ties (M-mode imaging and 2D imaging) and for each modality,
acquisitions were performed using FI and HI. Thus, for each
patient, echocardiographic images were captured in four
modes: M-mode FI, M-mode HI, 2D FI and 2D HI. All recorded
images were set up anonymous and randomly analysed on
nine separate tapes. In particular, the FI and HI tracings
for each patient were always recorded on different tapes.
Readings were performed after all recordings had been com-
t
S
(
wentricular septum; LA: left atrium; LVD: left ventricular diameter;
W: posterior wall.
leted. All measurements were read in a blind fashion and
ndependently by two experienced physicians (observer 1
O1; L.P.] and observer 2 [O2; N.M.]). The following variables
ere systematically measured in M-mode and in 2D mode:
nd-diastolic IVS, end-diastolic PW and end-diastolic LVD. In
-mode, all measurements were made using Penn and ASE
onventions [15] and in 2D mode, all measurements were
ade using the ASE convention. For each variable, the mean
f three different measurements was calculated. The M-
ode LV mass was calculated using corresponding equations
ASE: LV mass = 0.8[1.04(LVD + IVS + PW)3 — LVD3] + 0.6 g; and
enn: LV mass = 1.04[(LVD + IVS + PW)3 — LVD3]— 13.6 g), and
he 2D LV mass was calculated by applying the ASE M-
ode equation. Thus, for each patient, we obtained six
ets of LV measurements for O1 and six sets of LV mea-
urements for O2: M-mode FI (Penn), M-mode HI (Penn),
-mode FI (ASE), M-mode HI (ASE), 2D FI (ASE) and 2D HI
ASE) (Fig. 1). LV hypertrophy was deﬁned as LV mass greater
han 111 g/m2 in men and greater than 106 g/m2 in women
16,17].
tatistical analysis
tatistical analysis was performed with the Stata statis-
ical software package, version 8.0 (Stata Corp, College
tation, TX, USA) and Nquery advisor software, version 4
Statistical Solutions Ltd, Cork, Ireland). A paired t test
as used to compare LV mass estimates obtained by the
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Table 1 Left ventricular mass measurements and interobserver agreement over readings obtained in six different
echocardiographic modes.
M-mode Penn M-mode ASE Two-dimensional
Fundamental
imaging
Harmonic
imaging
Fundamental
imaging
Harmonic
imaging
Fundamental
imaging
Harmonic
imaging
LV mass by O1 (g)a 174.3 (42.1) 199.3 (47.5)* 171.5 (35.6) 196.3 (45.2)* 162.3 (34.9) 180.1 (38.8)*
LV mass by O2 (g)a 169.7 (46.1) 184.4 (46.9)** 174.5 (42.5) 182.9 (41.3)*** 175.0 (37.7) 188.5 (39.7)****
SD difference 32.6 28.7 29.2 30.4 27.9 22.3
95% limits of
agreement
[—69.9;60.6] [—72.3;42.4] [—55.4;61.4] [—74.3;47.6] [—43.2;68.6] [—36.2;53.2]
ICC 0.73 0.78 0.70 0.72 0.66 0.82
ASE: American Society of Echocardiography; I: imaging; intraclass correlation coefﬁcient; LV: left ventricular; O1: observer 1; O2:
observer 2; SD difference: standard deviation of the difference between the two observers. Comparison of LV mass in each mode
between fundamental and harmonic imaging: *P≤ 0.0005; **P = 0.007; ***P = 0.04; ****P = 0.0006.
a Values are mean (standard deviation).
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2ifferent echocardiographic modes and to compare echocar-
iographic measurements (mean LV estimates obtained by
1 and O2) with CMR measurements. Linear regression
nalysis was used to investigate the relationship between
ontinuous variables. Interobserver variability was assessed
y using:
the presence of a systematic difference between
two investigators (absolute value or percentage:
[O1—O2]/O1× 100);
the ICC and the 95% limits of agreement calculated using
the method of Bland and Altman [18].
To assess the interobserver variability in the diagnosis
f LV hypertrophy, a paired Chi2 test with one degree of
reedom was applied. The sample size required to detect a
linical change between paired observations in an exper-
mental study was calculated by using the formula for
etermination of sample size for the comparison of two
eans, taking paired data into account. These sample sizes
ere calculated using an alpha value of 0.05, a power of
0% or 90%, to expect either 10 or 20 g LV mass differences.
or each echocardiographic mode, we used the SD of the
ean difference between O1 and O2, where each measure
as itself the mean of three measurements. The variability
f echocardiographic LV mass measurement was expressed
y:
the presence of a systematic difference between echocar-
diography and CMR (absolute value or percentage: [LV
mass echocardiography—LV mass CMR]/LV mass echocar-
diography× 100; P < 0.05 was considered signiﬁcant);
the ICC.
esultsorty consecutive patients (32 men and eight women) were
ncluded. Mean (SD) age was 51 (10) years (range, 28—72
ears). Mean (SD) systolic blood pressure was 148 (20) mmHg
c
f
7
(range, 102—203mmHg); mean (SD) diastolic blood pressure
as 89 (13) mmHg (range, 61—121mmHg).
omparisons of left ventricular mass
alculated by echocardiography
or LV mass, signiﬁcant correlations were observed between
he different echocardiographic methods (r = 0.99 between
SE FI and Penn FI; r = 0.96 between ASE HI and Penn HI;
= 0.80 between Penn FI and Penn HI; r = 0.85 between ASE
I and ASE HI; r = 0.82 between 2D FI and 2D HI; P < 0.0001)
nd between O1 and O2 (r = 0.94 for Penn HI; r = 0.81 for
enn FI; r = 0.79 for ASE HI; r = 0.75 for ASE FI; r = 0.81 for
D HI; r = 0.75 for 2D FI). Regardless of the mode used
M-mode or 2D) or the observer (O1 or O2), LV mass was
igniﬁcantly higher with HI than with FI (Table 1). More-
ver, LV hypertrophy was more frequently found with HI
ompared with FI: using Penn M-mode, LV hypertrophy was
ound in 33% of patients using HI vs 13% of patients using FI
P = 0.04).
Interobserver reproducibility of readings has been eval-
ated. The ICC was slightly higher with HI than with FI, in
oth M-mode and 2D mode (Table 1). The best 95% limits
f agreement and the best ICC between O1 and O2 were
bserved with 2D HI (ICC, 0.82). According to Bland and
ltman plots, the limits of interobserver agreement were
ide for all methods (Fig. 2), but especially for FI. For FI,
he limits were between —61.4 and 55.4 g for M-mode ASE
onvention, —60.6 and 69.9 g for M-mode Penn convention,
nd —68.6 and 43.2 g for 2D mode. For HI, the limits were
47.6 and 74.3 g for M-mode ASE convention, —42.4 and
2.3 g for M-mode Penn convention, and —53.2 and 36.2 g for
D mode. The interobserver variability (expressed by per-
entage of the difference: ([O1—O2]/O1) was —1.3% (14.3%)
or ASE FI, 3.4% (18.3%) for Penn FI, —9.1% (17.9%) for 2D FI,
% (16.3%) for ASE HI, 8.4% (16.0%) for Penn HI and —4.7%
12.8%) for 2D HI.
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Figure 2. Bland and Altman analysis of interobserver reproducibility using fundamental imaging and harmonic imaging, according to
echocardiographic modalities (M-mode imaging or two-dimensional [2D] imaging). Dashed lines, 1.96 standard deviations from the mean.
ASE: American Society of Echocardiography; LV: left ventricular; O1: observer 1; O2: observer 2.
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Table 2 Comparison of left ventricular mass obtained using cardiac magnetic resonance and echocardiography.
LV mass (g)a d(echo-CMR) (g)a ICC P
CMR 162.1 (33.9)
M-mode Penn
Fundamental imaging 171.9 (41.0) 9.8 (29.2) 0.68 0.04
Harmonic imaging 191.9 (44.8) 29.8 (30.7) 0.5 < 0.0001
M-Mode ASE
Fundamental imaging 172.8 (36.2) 10.7 (26.1) 0.69 0.01
Harmonic imaging 189.8 (40.3) 27.6 (26.9) 0.53 < 0.0001
Two-dimensional
Fundamental imaging 168.5 (33.5) 6.4 (30.3) 0.59 0.25
Harmonic imaging 184.7 (38.0) 22.5 (29.1) 0.53 < 0.0001
ASE: American Society of Echocardiography; d(echo-CMR): left ventricular mass deviation between echocardiography and cardiac
magnetic resonance; ICC: intraclass correlation coefﬁcient; LV: left ventricular.
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omparison of left ventricular mass:
chocardiography vs cardiac magnetic
esonance
n the whole population, agreement (expressed by ICC)
etween CMR LV mass measurement and each echocardio-
raphic LV mass method measurement was similar, ranging
rom 0.5 to 0.69 (Table 2). All echocardiographic modes
igniﬁcantly overestimated LV mass compared with CMR,
xcept 2D FI. This overestimation was signiﬁcantly higher
sing HI compared with FI: 5.7% for M-mode FI (Penn conven-
ion) and 3.8% for 2D FI vs 15.5% for M-mode HI (Penn
onvention) and 12.2% for 2D HI (Table 2).
omparison of left ventricular mass according
o left ventricular geometryhe population was separated into two groups according
o the median value of the LV diastolic diameter for each
ethod (Table 3). For the smallest LV diameters (mean [SD]
t
T
s
Table 3 Indexed left ventricular mass measurements accordi
Echocardiographic modalities Large LV diastolic diameter
Valuea Range Median
Fundamental imaging
LV mass by M-mode Penn 93 (17) 65—128 92
LV mass by M-mode ASE 99 (17) 76—149 96
Two-dimensional LV mass 88 (13) 62—116 87
Harmonic imaging
LV mass by M-mode Penn 104 (17) 68—143 104
LV mass by M-mode ASE 109 (16) 87—149 107
Two-dimensional LV mass 97 (14) 67—128 99
ASE: American Society of Echocardiography; CMR: cardiac magnetic res
metre squares (g/m2).
a Values are mean (standard deviation).alue, 43 [2] mm; range, 39—48mm), there was good agree-
ent between CMR and all echocardiographic methods, with
CC ranging from 0.62 to 0.85. The same analysis performed
mong the largest LV diameters (mean [SD] value, 53 [3] mm;
ange, 49—60mm) demonstrated poor agreement between
MR and all echocardiographic methods, with ICC ranging
rom 0 to 0.22. Comparison of LV mass between 2D FI and
MR showed an ICC of 0 in the largest LV diameter group
nd an ICC of 0.82 in the smallest LV diameter group. The
ariability in LV mass measurement expressed as a percent-
ge ([LV mass echo—LV mass CMR]/LV mass echo× 100) was
.6% for M-mode FI (Penn convention) and 2.3% for 2D FI in
he group with the smallest left ventricles, and 9.6% for M-
ode FI (Penn convention) and 4.9% for 2D FI in the group
ith the largest left ventricles.
ample size of experimental study according
o echocardiographic modality
he inﬂuence of precision on the cost of an experimental
tudy, by calculating the sample size that would be needed
ng to the size of the left ventricle.
Small LV diastolic diameter
Echo—CMRa Valuea Range Median Echo—CMRa
8 (15) 85 (21) 55—153 86 2 (14)
13 (15) 81 (12) 63—108 79 3 (27)
3 (16) 83 (17) 64—142 80 0.3 (13)
19 (13) 93 (24) 58—159 89 10 (17)
24 (13) 88 (14) 62—116 92 3 (25)
12 (14) 92 (18) 65—143 90 9 (14)
onance; LV: left ventricular. All values are expressed in gram per
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Table 4 Estimation of sample size per group needed to detect a signiﬁcant change in mean left ventricular mass in
studies, according to the echocardiographic method used to calculate left ventricular mass.
 mass (g) Power (%) M-mode Two-dimensional
Penn FI (n) Penn HI (n) ASE FI (n) ASE HI (n) 2D FI (n) 2D HI (n)
10 80 168 131 135 147 124 80
10 90 225 175 181 197 165 106
20 80 43 34 35 38 32 21
20 90 57 45 46 50 42 28
ASE: American Society of Echocardiography; 2D: two-dimensional; FI: fundamental imaging; HI: harmonic imaging.
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tto detect a given change in LV mass, is presented in Table 4.
To detect a between-group difference of at least 10 g in the
change of LV mass with a power of 90%, 225 patients per
group would be necessary using Penn FI, compared with only
106 patients per group using 2D HI. Thus, by using a different
echocardiographic imaging modality for the calculation of LV
mass, the necessary sample size of an experimental study
could be decreased by 53%.
Discussion
In this study, we demonstrate that:
• HI overestimates LV mass measurement compared with
both FI and CMR, and that this leads to overestimation
of the prevalence of LV hypertrophy in a population of
hypertensive patients;
• HI improves interobserver reproducibility of LV mass mea-
surement compared with FI, leading to a signiﬁcant
decrease in the number of patients required for clinical
trials evaluating LV mass regression;
• accuracy of LV mass measurement using echocardiography
is affected by LV geometry.
Two echocardiographic studies have recently reported
that LV mass is overestimated using HI [6,19]. However, to
our knowledge, no previous study has compared echocardio-
graphy using FI and HI, and CMR. Our results conﬁrm that LV
mass is overestimated by M-mode HI compared with M-mode
FI and furthermore with the gold standard (i.e. CMR). The
difference between FI and HI is explained by modiﬁcation
of visualization of LV walls, and could be designated as a
‘‘reading effect’’ [6]; structures near to the septum, such
as the subvalvular tricuspid apparatus or LV false tendinae,
are more difﬁcult to individualize using HI. Interestingly, the
overestimation by HI may modify the clinical status of a sig-
niﬁcant number of patients wrongly classiﬁed as having LV
hypertrophy.
Assessment of LV mass needs to be accurate and repro-
ducible, allowing analysis of the modiﬁcation of LV values
and morphology, particularly in individual and research
studies [20—22]. LV mass measurement by CMR is actually
considered as the reference method, because correlations
and accuracy compared with true LV mass are excellent
[23—28]. However, CMR is not available in most centres
and its accessibility is restricted. Thus, many studies have
analysed the ability of different antihypertensive drugs to
p
t
h
oeduce LV mass in essential hypertension and the reliabil-
ty of echocardiographic LV mass measurement [7,9—16]. In
hese studies, although the 2D mode has not been speciﬁ-
ally validated [7,8], M-mode and 2D mode are indifferently
sed and the type of imaging (HI or FI) is not usually speci-
ed.
Interestingly, in our study, we found a sensible variation
n LV mass measurement according to the echocardiographic
ethods, in terms of both mean values and reproducibility.
n previous pharmacological studies [11,13], LV mass regres-
ion ranged from 5% (95% conﬁdence interval: 1.2—7.3%) to
5% (95% conﬁdence interval: 9.9—20.1%) and these values
re close to the values of LV mass interobserver variabil-
ty according to the echocardiographic methods observed in
ur study. This means that potential variation due to either
ethod applied is of the same magnitude as the difference
btained with treatment. The intraobserver variability is
orse. However, in these pharmacological studies, it was
ot speciﬁed that examinations were performed by the same
bserver. For this reason, in this study, we used interob-
erver variability in different echocardiographic methods for
he calculation of sample size. Fortunately, we found that
D HI had the best interobserver reproducibility and that
his could have a signiﬁcant clinical impact [29,30]. Thus,
n clinical trials dealing with LV hypertrophy regression, the
hoice of echocardiographic method could be of importance
ecause the use of 2D HI would reduce the sample size
equired in a two-group experiment by over 50% compared
ith M-mode FI. The LV mass measurement method used in
harmacological studies of LV mass regression should always
e mentioned, whereas at present, most studies do not
pecify the echocardiographic modality of acquisition and
eading.
In the present study, we have also shown that LV size inﬂu-
nces the calculation of LV mass. Indeed, we found excellent
ccuracy of echocardiography LV mass measurement com-
ared with CMR in a subgroup with smaller left ventricles,
ith low variability between echocardiography and CMR
ompared with results observed in the global population.
o geometric assumption is needed for the calculation of
V mass using CMR, allowing accurate and reliable LV mass
easurement, regardless of the LV shape observed [19]. On
he other hand, estimation of LV mass by echocardiogra-
hy assumes a prolate ellipsoid shape with a long-axis value
wice that of the small axis. Thus, when the left ventricle
as a normal shape, with a ratio of long- to short-axis length
f 2:1, the LV volume is accurately calculated as the cube of
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[50
he LV short-axis diameter [31,32]. In more dilated left ven-
ricles, the ratio is less than 2 and the use of a cube formula
s not accurate, as demonstrated in our study. Indeed, the
ccuracy of echocardiography for the calculation of LV mass
pplying the simpliﬁed model was very poor compared with
MR in the subgroup of patients with a large left ventricle.
M-mode FI is the only anatomically validated unidi-
ensional echocardiographic method [5,15]. Although used
y many laboratories and many research studies, the 2D
ethod has not been anatomically validated. However,
anadian guidelines noted that 2D echocardiography may
e an accurate and acceptable alternative for the calcula-
ion of LV mass, but that this could not yet be recommended
ecause of an absence of speciﬁc validation studies [7]. Our
tudy is the ﬁrst to validate this 2D method, compared with
-mode echocardiography and CMR, permitting wide use
f 2D echocardiography for the calculation of LV mass in
he parasternal view. Nevertheless, this method seems to
e the less accurate echocardiographic method in patients
resenting with a dilated left ventricle.
The main limitation of our study is the small number of
atients. However, due to the accuracy of CMR, which is well
ccepted as the gold standard for LV volumic assessment,
igniﬁcant differences in LV mass estimates were obtained
etween echocardiographic methods in these 40 patients.
onclusion
he present study demonstrates that HI overestimates LV
ass compared with FI and CMR. This overestimation can
ave a clinical impact, with an increase in the prevalence
f LV hypertrophy using such a method. However, harmonic
maging improves interobserver reproducibility, particularly
ith 2D imaging. This could also be clinically useful, as 2D
I would reduce the number of patients required for clini-
al trials evaluating LV mass regression. Physicians should be
lso aware that accuracy of LV mass calculation by echocar-
iography may be affected by the pattern of LV geometry,
s poor accuracy was observed between echocardiography
nd CMR in large left ventricles. To our knowledge, this is
he ﬁrst study validating the use of 2D imaging for the cal-
ulation of LV mass in the parasternal long-axis view, as this
ethod is at least as accurate as M-mode in a non-selected
ypertensive population.
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